In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres
- 15 June 2000
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 67 (1) , 19-28
- https://doi.org/10.1016/s0168-3659(99)00289-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Physico-chemical parameters governing protein microencapsulation into biodegradable polyesters by coacervationInternational Journal of Pharmaceutics, 1997
- Characterization and morphological analysis of a cholecystokinin derivative peptide-loaded poly(lactide-co-glycolide) microspheres prepared by a water-in-oil-in-water emulsion solvent evaporation methodJournal of Controlled Release, 1997
- Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune responseJournal of Controlled Release, 1996
- Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patientsMetabolism, 1995
- The preparation and characterization ofpoly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model proteinInternational Journal of Pharmaceutics, 1994
- Factors influencing the release of peptides and proteins from biodegradable parenteral depot systemsJournal of Controlled Release, 1992
- Vapreotide, a somatostatin analogue, in cryptosporidiosis and other AIDS-related diarrhoeal diseasesAIDS, 1992
- Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.Proceedings of the National Academy of Sciences, 1986
- Characterization of Drug-Loaded Poly(d,l-lactide) MicrospheresJournal of Pharmaceutical Sciences, 1984
- A New Long-Acting Injectable Microcapsule System for the Administration of ProgesteroneFertility and Sterility, 1979